Revolutionizing Biotechnology

The immune-functional Golden Eggs™ are developed in large-scale mass production, and premium offerings targeted at high-net-worth individuals. This product is designed to comprehensively boost human immunity and stimulate the body’s endogenous hormones to defend against microbiological infections and external harmful factors. It is suitable for all genders and age groups, including children, middle-aged adults and the elderly.

Laying hens will be fed with CBI proprietary formulated feed, and injected with functional inducing factor adjuvants to produce the targeted immune eggs which produce specific IgY in the yolk.

Currently a prototype of immune-boosting Golden Egg™ are produced in our laboratory facilities and in the testing. The products are refined for commercialization.

Our immunotherapy platform harnesses the power of the immune system to fight cancer and other diseases, using various proteins, engineered immune stem cells and other novel approaches.

Our cell therapy expertise allows us to engineer cells to target and treat a range of diseases, including cancer, autoimmune disorders, and more.

Our regenerative medicine solutions use stem cells and other advanced techniques to repair and replace damaged tissues, potentially providing a cure for previously untreatable conditions.

Our AI-powered drug discovery and development platform uses machine learning and other advanced techniques to accelerate the discovery of new treatments.

Our bioengineering expertise enables us to create novel biomaterials, implants, and other medical devices, improving patient outcomes and quality of life.